Evidence map›Paper›PMID 34232082›Full record

Trial reportmSphere2021

Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.

Zhaoyong Ba, Yujin Lee, Huicui Meng, Penny M Kris-Etherton, Connie J Rogers, Zachery T Lewis, David A Mills, Emily J Furumoto, M Laura Rolon, Jennifer A Fleming and 1 more

Open access · goldAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Frontiers in nutrition · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhaoyong BaDepartment of Food Science, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Yujin LeeDepartment of Nutritional Sciences, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Huicui MengDepartment of Nutritional Sciences, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Penny M Kris-EthertonDepartment of Nutritional Sciences, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Connie J RogersDepartment of Nutritional Sciences, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Zachery T LewisDepartment of Food Science and Technology, University of California, Davis, California, USA.
David A MillsDepartment of Food Science and Technology, University of California, Davis, California, USA.
Emily J FurumotoDepartment of Food Science, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
M Laura RolonDepartment of Food Science, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Jennifer A FlemingDepartment of Nutritional Sciences, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Robert F RobertsDepartment of Food Science, The Pennsylvania State Universitygrid.29857.31, University Park, Pennsylvania, USA.
Pennsylvania State University · USUniversity of California, Davis · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR000127 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$17.1M
Activation of probiotic bifidobacteria by milk glyansR01AT008759 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GERMAN, BRUCE, LEBRILLA, CARLITO B · 2014 to 2018
$4.2M
Mechanism of Activation of Probiotic Bifidobacteria by Prebiotic Milk GlycansR01AT007079 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GERMAN, BRUCE, LEBRILLA, CARLITO B · 2012 to 2016
$2.2M
NCATS NIH HHS UL1 TR000127NCCIH NIH HHS R01 AT007079NCCIH NIH HHS R01 AT008759
6 · The paper itself

Abstract

Probiotics are consumed in fermented dairy products or as capsules for their putative health benefits. However, little research has been done to evaluate the effects of the delivery matrix on the health benefits of probiotics in humans. To examine the effects of delivering Bifidobacterium animalis subsp.

Indexed as

Gastrointestinal MicrobiomeAdultBifidobacterium animalisCapsulesCross-Over StudiesFatty Acids, VolatileFecesFermentationHealthy VolunteersHumansProbioticsRNA, Ribosomal, 16SYogurtCapsulesFatty Acids, VolatileRNA, Ribosomal, 16SBB-12gut microbiotagut transit timeprobioticsshort-chain fatty acids

Identifiers

PMID34232082
PMCPMC8386398
OpenAlexW3181570713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.